Clinical Trials
7
Active:1
Completed:4
Trial Phases
4 Phases
Phase 1:3
Phase 3:1
Phase 4:1
+1 more phases
Drug Approvals
14
PPB:14
Drug Approvals
OKEDI POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION 100MG
- Approval Date
- Sep 26, 2023
PPB
OKEDI POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION 75MG
- Approval Date
- Sep 26, 2023
PPB
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (42.9%)Not Applicable
2 (28.6%)Phase 3
1 (14.3%)Phase 4
1 (14.3%)Evaluate the Effect of Dietary Supplement Combined Exercise Among Patients With Sarcopenia Comorbid With Lung Disease
Not Applicable
Recruiting
- Conditions
- SarcopeniaCOPDILD
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2023-07-03
- Lead Sponsor
- Orient Europharma Co., Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT05926713
- Locations
- 🇨🇳
Taichung Veterans General Hospital, Taichung, Taiwan
A Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Symptomatic Knee Osteoarthritis
- First Posted Date
- 2023-04-11
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Orient Europharma Co., Ltd.
- Target Recruit Count
- 136
- Registration Number
- NCT05807529
- Locations
- 🇨🇳
Tri-Service General Hospital, Taipei, Taiwan
Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide)
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2021-04-30
- Lead Sponsor
- Orient Europharma Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT04349696
- Locations
- 🇨🇳
Chiayi Chang Gung Memorial Hospital, Chiayi City, Taiwan
🇨🇳Taipei Veterans General Hospital, Taipei, Taiwan
2ccPA Study in Patients With Symptomatic Knee Osteoarthritis
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2021-04-30
- Lead Sponsor
- Orient Europharma Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT04229394
- Locations
- 🇨🇳
Veteran General Hospital Taipei, Taipei, Taiwan
🇨🇳Tri-Service General Hospital, Taipei, Taiwan
🇨🇳Mackay Memorial Hospital, Taipei, Taiwan
Evaluate the Effect of Dietary Supplement on Muscle Mass and Physical Performance for Over 50 Years Old People
Not Applicable
Completed
- Conditions
- Muscle Loss
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2021-04-30
- Lead Sponsor
- Orient Europharma Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT04229407
- Locations
- 🇨🇳
Veteran General Hospital-Taipei, Taipei, Taiwan
- Prev
- 1
- 2
- Next
News
No news found